Extracellular matrix metalloproteinase inducer (CD147) and membrane type 1-matrix metalloproteinase are expressed on tissue macrophages in calcific aortic stenosis and induce transmigration in an artificial valve model

Journal of Thoracic and Cardiovascular Surgery

Volumn 142, Issue 1, 2011, Pages 191-198

  Joghetaei, Nader ^a   Akhyari, Payam ^b   Rauch, Bernhard H ^b   Cullen, Paul ^c   Lichtenberg, Artur ^b   Rudelius, Martina ^a   Pelisek, Jaroslav ^a   Schmidt, Roland ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c Heine University ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CD147 ANTIGEN; MATRIX METALLOPROTEINASE 14; SMALL INTERFERING RNA; BETA ACTIN; CD68 ANTIGEN; GELATINASE A; GELATINASE B; ILOMASTAT;

AORTA STENOSIS; ARTICLE; BIOCHEMISTRY; CELL MIGRATION; CLINICAL ARTICLE; CONTROLLED STUDY; GENE SILENCING; HEART TRANSPLANTATION; HEART VALVE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; ISCHEMIC HEART DISEASE; MACROPHAGE; MONOCYTE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; WESTERN BLOTTING; AORTA VALVE; AORTA VALVE STENOSIS; BIOCHEMICAL ANALYSIS; BREAST CANCER; CALCIFIC AORTIC STENOSIS; CELL SURFACE; ENDOTHELIUM CELL; ENZYME ACTIVITY; HUMAN TISSUE; IMMUNOFLUORESCENCE; IMMUNOREACTIVITY; IN SITU GELATIN ZYMOGRAPHY; ISCHEMIC CARDIOMYOPATHY; ZYMOGRAPHY;

ANTIGENS, CD147; AORTIC VALVE; AORTIC VALVE STENOSIS; BLOTTING, WESTERN; CALCINOSIS; CARDIOMYOPATHIES; CELLS, CULTURED; COCULTURE TECHNIQUES; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MATRIX METALLOPROTEINASE 14; RNA INTERFERENCE; TRANSENDOTHELIAL AND TRANSEPITHELIAL MIGRATION;

EID: 79959339589     PISSN: 00225223     EISSN: 1097685X     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2010.09.051     Document Type: Article

References (36)

1. B. Iung, G. Baron, E.G. Butchart, F. Delahaye, C. Gohlke-Barwolf, and O.W. Levang A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease Eur Heart J 24 2003 1231 1243 (Pubitemid 36834640)
2. V. Babaliaros, and P. Block State of the art percutaneous intervention for the treatment of valvular heart disease: a review of the current technologies and ongoing research in the field of percutaneous valve replacement and repair Cardiology 107 2007 87 96 (Pubitemid 46277048)
3. R. Rosenhek, and H. Baumgartner Aortic sclerosis, aortic stenosis and lipid-lowering therapy Expert Rev Cardiovasc Ther 6 2008 385 390
4. S. Helske, M. Kupari, K.A. Lindstedt, and P.T. Kovanen Aortic valve stenosis: an active atheroinflammatory process Curr Opin Lipidol 18 2007 483 491 (Pubitemid 47462199)
5. J.D. Miller, Y. Chu, R.M. Brooks, W.E. Richenbacher, R. Peña-Silva, and D.D. Heistad Dysregulation of antioxidant mechanisms contributes to increased oxidative stress in calcific aortic valvular stenosis in humans J Am Coll Cardiol 52 2008 843 850
6. G.J. Koullias, D.P. Korkolis, P. Ravichandran, A. Psyrri, I. Hatzaras, and J.A. Elefteriades Tissue microarray detection of matrix metalloproteinases, in diseased tricuspid and bicuspid aortic valves with or without pathology of the ascending aorta Eur J Cardiothorac Surg 26 2004 1098 1103 (Pubitemid 39487454)
7. E. Aikawa, M. Aikawa, P. Libby, J.L. Figueiredo, G. Rusanescu, and Y. Iwamoto Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease Circulation 119 2009 1785 1794
8. E. Aikawa, M. Nahrendorf, J.L. Figueiredo, F.K. Swirski, T. Shtatland, and R.H. Kohler Osteogenesis associates with inflammation in early-stage atherosclerosis evaluated by molecular imaging in vivo Circulation 116 2007 2841 2850 (Pubitemid 350301146)
9. E. Aikawa, M. Nahrendorf, D. Sosnovik, V.M. Lok, F.A. Jaffer, and M. Aikawa Multimodality molecular imaging identifies proteolytic and osteogenic activities in early aortic valve disease Circulation 115 2007 377 386 (Pubitemid 46148512)
10. N.M. Rajamannan, M. Subramaniam, F. Caira, S.R. Stock, and T.C. Spelsberg Atorvastatin inhibits hypercholesterolemia-induced calcification in the aortic valves via the Lrp5 receptor pathway Circulation 112 2005 I229 I234
11. I. Inoue, S. Goto, T. Awata, T. Mastunaga, S. Kawai, and T. Nakijama Lipophilic HMG-CoA reductase inhibitor has an anti-inflammatory effect: reduction of MRNA levels for interleukin-1beta, interleukin-6, cyclooxygenase-2, and p22phox by regulation of peroxisome proliferator-activated receptor alpha (PPARalpha) in primary endothelial cells Life Sci 67 2000 863 876 (Pubitemid 30491080)
12. R.S. Rosenson, C.C. Tangney, and L.C. Casey Inhibition of proinflammatory cytokine production by pravastatin Lancet 353 1999 983 984 (Pubitemid 29132615)
13. U. Laufs, D. Marra, K. Node, and J.K. Liao 3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1) J Biol Chem 274 1999 21926 21931
14. A. Kizu, A. Shioi, S. Jono, H. Koyama, Y. Okuno, and Y. Nishizawa Statins inhibit in vitro calcification of human vascular smooth muscle cells induced by inflammatory mediators J Cell Biochem 93 2004 1011 1019 (Pubitemid 44264154)
15. K.L. Chan, K. Teo, J.G. Dumesnil, A. Ni, J. Tam ASTRONOMER Investigators Effect of Lipid lowering with rosuvastatin on progression of aortic stenosis: results of the aortic stenosis progression observation: measuring effects of rosuvastatin (ASTRONOMER) trial Circulation 121 2010 306 314
16. A.C. Newby Metalloproteinase expression in monocytes and macrophages and its relationship to atherosclerotic plaque instability Arterioscler Thromb Vasc Biol 28 2008 2108 2114
17. C. Biswas, Y. Zhang, R. DeCastro, H. Guo, T. Nakamura, and H. Kataoka The human tumor cell-derived collagenase stimulatory factor (renamed EMMPRIN) is a member of the immunoglobulin superfamily Cancer Res 55 1995 434 439
18. R. Schmidt, A. Bültmann, M. Ungerer, N. Joghetaei, Ö Bülbül, and S. Thieme EMMPRIN regulates MMP activity in cardiovascular cells. Implications in acute myocardial infarction Circulation 113 2006 834 841
19. R. Schmidt, V. Redecke, Y. Breitfeld, N. Wantia, T. Miethke, and S. Massberg EMMPRIN (CD 147) is a central activator of extracellular matrix degradation by Chlamydia pneumoniae-infected monocytes. Implications for plaque rupture Thromb Haemost 95 2006 151 158
20. A.E. May, V. Redecke, S. Grüner, R. Schmidt, S. Massberg, and T. Miethke Recruitment of Chlamydia pneumoniae-infected macrophages to the carotid artery wall in noninfected, nonatherosclerotic mice Arterioscler Thromb Vasc Biol 23 2003 789 794 (Pubitemid 36566167)
21. C. Badier-Commander, T. Verbeuren, C. Lebard, J.B. Michel, and M.P. Jacob Increased TIMP/MMP ratio in varicose veins: a possible explanation for extracellular matrix accumulation J Pathol 192 2000 105 112
22. M.M. Bradford A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
23. V. Masson, L.R. de la Ballina, C. Munaut, B. Wielockx, M. Jost, and C. Maillard Contribution of host MMP-2 and MMP-9 to promote tumor vascularization and invasion of malignant keratinocytes FASEB J 19 2005 234 236 (Pubitemid 40189266)
24. M. Klouche, A.E. May, M. Hemmes, M. Messner, S.M. Kanse, and K.T. Preissner Enzymatically modified, nonoxidized LDL induces selective adhesion and transmigration of monocytes and T-lymphocytes through human endothelial cell monolayers Arterioscler Thromb Vasc Biol 19 1999 784 789
25. S.D. Sithu, W.R. English, P. Olson, D. Krubasik, A.H. Baker, and G. Murphy Membrane-type 1-matrix metalloproteinase regulates intracellular adhesion molecule-1 (ICAM-1)-mediated monocyte transmigration J Biol Chem 282 2007 25010 25019 (Pubitemid 47347548)
26. J. Fielitz, M. Leuschner, H.R. Zurbrügg, B. Hannack, R. Pregla, and R. Hetzer Regulation of matrix metalloproteinases and their inhibitors in the left ventricular myocardium of patients with aortic stenosis J Mol Med 82 2004 809 820
27. N.E. Sounni, L. Devy, A. Hajitou, F. Frankenne, C. Munaut, and C. Gilles MT1-MMP expression promotes tumor growth and angiogenesis through an up-regulation of vascular endothelial growth factor expression FASEB J 16 2002 555 564 (Pubitemid 34273239)
28. A. Parolari, C. Loardi, L. Mussoni, L. Cavallotti, M. Camera, and P. Biglioli Nonrheumatic calcific aortic stenosis: an overview from basic science to pharmacological prevention Eur J Cardiothorac Surg 35 2009 493 504
29. B. Jian, P.L. Jones, Q. Li, E.R. Mohler 3rd, F.J. Schoen, and R.J. Levy Matrix metalloproteinase-2 is associated with tenascin-C in calcific aortic stenosis Am J Pathol 159 2001 321 327 (Pubitemid 33704217)
30. T. Sameshima, K. Nabeshima, B.P. Toole, K. Yokogami, Y. Okada, and T. Goya Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts Cancer Lett 157 2000 177 184 (Pubitemid 30629029)
31. G. Hekimian, S. Passefort, L. Louedec, X. Houard, M.P. Jacob, and A. Vahanian High-cholesterol + vitamin D2 regimen: a questionable in-vivo experimental model of aortic valve stenosis J Heart Valve Dis 18 2009 152 158
32. T. Igakura, K. Kadomatsu, T. Kaname, H. Muramatsu, Q.W. Fan, and T. Miyauchi A null mutation in basigin, an immunoglobulin superfamily member, indicates its important roles in peri-implantation development and spermatogenesis Dev Biol 194 1998 152 165 (Pubitemid 28117579)
33. S. Reinboldt, F. Wenzel, B.H. Rauch, T. Hohlfeld, M. Grandoch, and J.W. Fischer Preliminary evidence for a matrix metalloproteinase-2 (MMP-2)-dependent shedding of soluble CD40 ligand (sCD40L) from activated platelets Platelets 20 2009 441 444
34. L. Menchén, I. Marín-Jiménez, E.G. Arias-Salgado, T. Fontela, P. Hernández-Sampelayo, and M.C. Rodríguez Matrix metalloproteinase 9 is involved in Crohn's disease-associated platelet hyperactivation through the release of soluble CD40 ligand Gut 58 2009 920 928
35. R. Schmidt, A. Bültmann, S. Fischel, A. Gillitzer, P. Cullen, and A. Walch Extracellular matrix metalloproteinase inducer (CD147) is a novel receptor on platelets, activates platelets, and augments nuclear factor kappaB-dependent inflammation in monocytes Circ Res 102 2008 302 309 (Pubitemid 351271650)
36. J.J. Kaden, R. Kili, A. Sariko, S. Hagl, S. Lang, and U. Hoffmann Tumor necrosis factor alpha promotes an osteoblast-like phenotype in human aortic valve myofibroblasts: a potential regulatory mechanism of valvular calcification Int J Mol Med 16 2005 869 872